BLACK BOX WARNING: GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome type 2
As we said, B12 is needed for the maintenance of the myelin sheath
(accessed June 2022) 12Exendin-4: From lizard to laboratoryand beyond
The question of whether Ozempic can be safely used in patients with Crohn's disease requires careful consideration, as there is no official contraindication listed in the Summary of Product Characteristics (SmPC) specifically for inflammatory bowel disease
K.PerelmanD.DahanD.MerrillB
Clinical Study Data: PIONEER Trials (Oral Semaglutide): PIONEER 1 (Oral Semaglutide vs Placebo): 14 mg oral semaglutide: 4.2 kg (9.3 pounds) average weight loss Placebo: 0.8 kg (1.8 pounds) average weight loss Duration: 26 weeks Conclusion: Modest weight loss, far below injectable results PIONEER 4 (Oral vs Injectable Semaglutide Direct Comparison): 14 mg oral semaglutide daily: 3.7 kg (8.2 pounds) 1.0 mg injectable semaglutide weekly: 5.0 kg (11 pounds) Even at lower injectable dose, injections produced 35% more weight loss Duration: 26 weeks Real-World Effectiveness: Doctors report that real-world results with Rybelsus are often worse than clinical trials because: Adherence Challenges: Must take on empty stomach first thing in morning 30-minute wait before eating or drinking anything else Patients frequently forget or break the rules Each missed or improperly taken dose reduces effectiveness Food Interference: Coffee with oral medication: Dramatically reduces absorption Taking with food: Almost completely prevents absorption Taking with other medications: May interfere with absorption Patient Expectations: Many patients expect oral semaglutide to work as well as injections, leading to disappointment and discontinuation
.jpg?ver=1765877054)
